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INTRODUCTION
Neurodegenerative diseases have disrupted neuronal homeostasis and their pathologies often overlap. Protein aggregates containing a-synuclein (a-syn), which eventually forms larger Lewy bodies (LBs), are seen in Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy, and in some forms of Alzheimer's disease (AD), all neurodegenerative diseases associated with aging (Arima et al., 1999; Francis, 2009; Lippa et al., 1998) . Often, the protein aggregates contain hyperphosphorylated tau and ubiquitin (Jellinger and Attems, 2008) .
Neurodegenerative events in these diseases are linked to inflammation (Mrak and Griffin, 2007; Tansey et al., 2008) , but, despite this link, defects in genes regulating inflammation do not have an established causative role in neurodegeneration. We report that deletion of Ifnb, which encodes interferon-b (IFN-b), is sufficient to cause a cascade of neurodegenerative events. IFN-b belongs to the type I interferon family of cytokines and binding to its receptor, interferon-a/b receptor (IFNAR), results in immunoregulation including anti-viral and anti-inflammatory effects (Prinz et al., 2008; Teige et al., 2003 Teige et al., , 2006 and benefits for multiple sclerosis patients (Liu et al., 2014; Yong et al., 1998) . However, the role of IFN-b in classic neurodegenerative diseases is unknown. We report that Ifnb -/-mice developed spontaneous pathologies mimicking major aspects of human neurodegeneration such as PD and DLB. Ifnb -/-mice had ageassociated motor learning defects, neuromuscular deficiencies, and cognitive impairment. Ifnb -/-pathology was associated with
LBs resulting from defective neuronal autophagy. Autophagy, a pathway that degrades long-lived proteins, organelles, lipids, and protein aggregates, is essential for neuronal homeostasis (Harris and Rubinsztein, 2012) , and deleting neural autophagyregulating genes leads to neurodegeneration (Hara et al., 2006; Komatsu et al., 2006) . Our findings indicate a central role for IFN-b in neuronal homeostasis as a regulator of autophagy-mediated protein degradation and accentuates Ifnb -/-mice as a model for neurodegenerative diseases with a-synucleinopathy and dementia such as PD and DLB.
RESULTS

Ifnb -/-Mice Exhibit Behavioral and Cognitive
Impairments and Neurodegeneration
We examined the effect of Ifnb gene deletion on motor coordination, learning, and grip strength. Ifnb -/-mice were significantly impaired in motor coordination and learning from 3 months (G) TUNEL staining of hippocampus from 1.5-month-old mice with methyl green nuclear counterstaining. MoDG, molecular dentate gyrus; GrDG, granular dentate gyrus; alv, alveus. (Table S1 ).
IFN-b Is Essential for Neuronal Survival, Neurite Outgrowth, and Branching
We investigated whether Ifnb -/-behavioral deficits were associated with neurodegeneration. Apoptotic cells were detected in 1.5-month-old Ifnb -/-granular layers of olfactory bulbs (Figure S1E) , the granular dentate gyrus of hippocampus and the subventricular zone ( Figure 1G ), and the striatum (STR) caudate putamen including the ependymal cell layer in 12-month-old Ifnb -/-mice ( Figure S1F ), but not detected in Ifnb +/+ sagittal brain sections at similar ages. Apoptotic neurons increased in cultured Ifnb -/-primary cerebellar granular neurons (CGNs) and was reversed by recombinant (r) . Neurons were significantly reduced in the hippocampal CA1 region in 3-to 6-month-old Ifnb -/-mice and decreased in Purkinje cells of cerebellum. Glial cell counts were unchanged (Figures 1H and 1I) . Supporting in vivo deficits in neuronal circuits, Ifnb -/-mice had reduced neurite network formation in the cerebellum, frontal cortex, and hippocampus granular cell layer ( Figure 1J ). This was confirmed in cultured Ifnb -/-primary cortical neurons (CNs) that had reduced neurite length per cell, mean length, and branch length per cell after 4 days, with restoration by rIFN-b ( Figures 1K and 1L) . A similar trend was seen after 21 days of culture ( Figure 1K ) and WT littermates were injected with bromodeoxyuridine (BrdU). Lack of Ifnb or receptor was associated with reduced neurogenesis in the hippocampus; dentate gyrus ( Figure 2I ), supporting the microarray data. IFN-b might directly affect prosurvival mechanisms as neurotrophin was among the top hits in gene set enrichment analysis (GSEA) ( Table S2 ) and mRNA for the corticogenesis-regulating transcription factor Tox (Artegiani et al., 2015) Figure 2J ), supporting that common pathways link neurodegenerative diseases (Shulman and De Jager, 2009) . We compared the Ifnb -/-neuronal gene profile with PD
and HD mouse models (Fossale et al., 2011) . Three sets of differentially expressed genes were generated: differentially expressed in our data (p < 0.001), in our data and the HD model (p < 0.01), or our data and the PD model (p < 0.01) (Figures S2A-S2C ; Data S1 Data are mean ± SEM, n = 3-4, counting 11-32 cells per experiment. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA. See also Figure S1 and Table S1 . Among differentially expressed genes in Ifnb -/-neurons, 31 (p = 6.937e-4) were involved in regulating dopamine (DA) signaling ( Figure 2P ), which is involved in coordinating movements. DA signaling was also defective in the STR. No major differences were found in levels of DA or its metabolite homovanillic acid (HVA) (data not shown) in 3-to 6-month-old Ifnb -/-mice, but the DA metabolite dihydroxyphenylacetic acid (DOPAC) was significantly lower, thus significantly affecting DA/DOPAC and DOPAC/HVA ratios ( Figure 2Q ). These findings support the importance of IFN-b in regulating dopamine turnover and protecting dopaminergic neurons.
Lack of Neuronal IFN-b-IFNAR Signaling Causes Lewy Bodies
Since Ifnb -/-mice defects overlapped with neurodegenerative diseases, particularly PD, we examined Ifnb -/-brain pathology.
Gross anatomy was unchanged, but histological examination showed that Ifnb -/-neuron degeneration was associated with age-dependent a-synucleinopathy. Staining for a-syn was normal in 1.5-month-old Ifnb -/-brains; by 3 months, a-syn was found in LB-like structures in SN; however, a-syn staining intensity was reduced in 12-month-old Ifnb -/-mice (Figures S3A and S3B), likely reflecting degeneration of TH + neuron ( Figure 2L ).
Alpha-syn and large pathogenic aggregates of phosphorylated (pSer129) a-syn were found in TH + DA neurons of SN ( Figure 3A ).
At 3 months, a-syn aggregates were widespread in the STR, frontal cortex ( Figure 3B ), hippocampus, and cerebellum (Figures S3C and S3D) . Alpha-syn + aggregates and neurites were found sporadically in thalamus, the brainstem, and subthalamic regions of 3-month-old Ifnb -/-mice ( Figures S3E-S3G ). Neurons with a-syn + LB-like structures increased with age (6-and 12-month-old) in Ifnb -/-mouse thalamus ( Figures 3C and 3D ). Whole-brain protein extracts from 1.5-month-old mice were not different from WT, but 3-month-old mice had significantly increased a-syn in insoluble fractions and no difference in soluble fractions ( Figures 3E-3I) . No difference in mRNA for a-syn was observed between Ifnb -/-and WT brains ( Figure 3J) ; thus, the a-syn accumulation was not due to increased transcription. The insoluble a-syn fraction in the BG (including SN) was significantly higher in older mice, but the soluble fraction was still unchanged. A significant increase in high-molecular-weight dimeric, trimeric, and oligomeric a-syn were seen in Ifnb -/-mice, but with a decrease in tetramers. While aggregated a-syn oligomers are neurotoxic (Rockenstein et al., 2014) , a-syn tetramers are suggested to be the normal aggregation resistant conformation of the protein (Bartels et al., 2011; Wang et al., 2011) , possibly explaining the tetramer abundance in Ifnb +/+ mice. pSer129-a-syn, which is prone to form pathogenic fibrillar aggregates, was increased in
regarding a-syn and pSer129-a-syn accumulation ( Figure S3H ). Blocking with a-syn 96-140 peptide confirmed specific immunoreactivity for a-syn in Ifnb -/-brains. To ensure that lack of Ifnb did not generate crossreacting a-syn-independent aggregates, we generated Scna
Accumulated polyubiquitinated proteins are associated with neurodegenerative disease (Davies et al., 1997; Hara et al., 2006; Komatsu et al., 2006 (Q) High-performance liquid chromatography (HPLC) analysis of DA, DOPAC, and HVA in STR of 3-to 6-month-old mice, n = 9-10/group. For (I), (K), (L), (N), and (Q), *p < 0.05, **p < 0.01, ***p < 0.001, by Student's t test. See also Figure S2 and Data S1. cerebellum, granular and molecular layers ( Figure S3N) 
Lack of IFN-b Affects Autophagy
We used GSEA to identify cellular pathways involved in Ifnb -/-neuron pathology. In the top 20 deregulated pathways, three were associated with autophagy, which were restored with rIFN-b ( Figure 4A ; Table S2 ). The autophagy system uses adaptor proteins SQSTM1/p62 (hereafter p62) and NBR1 to bind ubiquitinated proteins and LC3B-II in the autophagosomal isolation membrane. Upon autophagy, cytosolic LC3B-I is converted to membrane bound LC3B-II and blocking autophagy flux, e.g., with Rab7 defects (Gutierrez et al., 2004; Hyttinen et al., 2013) , causes accumulation of autophagy-targeted proteins; p62, NBR1, LC3B-II, and organelles. Increased neurons with accumulated p62 were seen in 3-month-old Ifnb -/-brains compared to WT, predominantly in brainstem, without increased p62 mRNA. LC3B-II increased in BG of 1.5-month-old Ifnb -/-, correlating with increased p62, NBR1 and Rab7, supporting defects in autophagy before a-syn, ubiquitin, pTau, and LB aggregation. Autophagy was even more deregulated in 6-to 8-month Ifnb -/-brains ( Figures 4B-4H ). Defective autophagy was also confirmed in Ifnar -/-mice ( Figure S4 ). Figure S5C ). To validate a block in autophagy flux, fusion between autophagosomes and lysosomes was inhibited with NH 4 Cl. At 1 hr, LC3B-II levels saturated in both genotypes, which correlated with a significant increase in p62 in Ifnb +/+ CNs; however, Ifnb -/-CNs had nearly saturated p62 levels without treatment, and no significant increase was seen with NH 4 Cl ( Figures 5C and 5D ). Autophagy flux was measured in CNs with the mRFP-GFP-LC3B construct, which emits mRFP and GFP signal in autophagosomes and only mRFP in autolysosomes because of low pH in the latter. Ifnb -/-CNs developed ubiquitin + a-syn aggregates and increased monomeric and high-molecular-weight a-syn after 21 days of culture ( Figures 6A and 6B ). Accumulation of a-syn was not due to proteasomal defects; turnover of the proteasome substrate p53 after cycloheximide treatment and proteasomal catalytic activity were uncompromised in Ifnb -/-CNs and unchanged by rIFN-b ( Figure S6 ). Blocking autophagy flux increased LC3B-II and a-syn, and a-syn colocalized with LC3B + and p62 + autophagosomes in Ifnb -/-CNs ( Figures 6C and 6D Figures 7A-7D ). Effects of rapamycin, an mTOR-dependent autophagy activator, were similar to rIFN-b, but the mTOR-independent inducer trehalose more efficiently reduced a-syn in CNs from both genotypes, possibly through increased a-syn secretion (Ejlerskov et al., 2013) . To ensure reconstitution of the genetic defect, we cultured Ifnb -/-neurons with a low rIFN-b dose for 21 days, which increased autophagy flux and a-syn clearance to the level in Ifnb +/+ neurons ( Figures 7E and 7F ).
Ifnb Gene Therapy Prevents Dopaminergic Neuron Loss in a Familial PD Model
We used lentiviruses to overexpress IFN-b to examine effects on a familial PD model induced with human a-syn (hSCNA) in rat SNs. Injection of hSCNA and control lentiviruses blocked autophagy indicated by accumulated LC3B-II, p62, NBR1, Beclin1, and hSCNA in BG 10 days after SN injection (Decressac et al., 2013) (Figures 7G and 7H) . Ifnb overexpression prevented hSCNA and pSer129-a-syn accumulation and restored TH loss. The mice showed improved left paw use compared to right paw use; contralateral to injection side of hSCNA/Ifnb and hSCNA/control viruses, respectively, 21 days post injection, which was associated with preservation of TH + fibers in SN (Figures 7I and 7J) . Ifnb gene therapy also significantly protected TH + dopaminergic neurons from hSCNA-induced SN damage ( Figure 7K ). Thus, IFN-b prevented pathology in a familial model of PD by inducing autophagy and a-syn clearance.
DISCUSSION
CNS immune activation and inflammation occur in neurodegenerative diseases (Brochard et al., 2009; Lee et al., 2009; Maccioni et al., 2009; Tansey et al., 2008) , but their role in initiation is unclear. We report that defects in IFN-b-IFNAR signaling, that is central to immune regulation, trigger neurodegeneration in the CNS of aging mice. IFN-b promotes neurite growth and protein degradation by autophagy. Lack of IFN-b causes neural pathological changes: accumulation of LB-like structures, neural apoptosis, and neurogenesis defects. p62 accumulated in Ifnb -/-brainstems and BG regions before pathological a-syn aggregation. Aggregates and LB-like structures with a-syn were seen in brainstem and BG including SN, cortex, thalamus, and cerebellum as previously reported in PD and DLB patients (Goedert et al., 2013; Mori et al., 2003) . IFN-b is expressed by neurons to prevent malignant growth (Liu et al., 2013) and neuroinflammation (Liu et al., 2014) and is produced by choroid plexus epithelial cells in aged mouse and human brains without CNS disease (Baruch et al., 2014) . In the latter study, injection of an anti-IFNAR antibody in the cerebrospinal fluid, however, positively affected some aspects of cognition. This approach could have complications as injection of full-length antibody might initiate complement-dependent cytotoxicity (Nelson, 2010) and inflammation (Congdon et al., 2013; Linnartz et al., 2012) and cause rapid antibody clearance compared to isotype controls (Sheehan et al., 2006 For (B), (C), (F), (H), and (N), */ # p < 0.05, **p < 0.01, ***/ ### p < 0.001 by unpaired Student's t test. See also Figure S4 and Table S2 . (legend continued on next page) a-syn in PD (Thenganatt and Jankovic, 2014) . Overexpression of disease-associated proteins (Arima et al., 1999; Jellinger, 2000; Lippa et al., 1998) 
and nes
Cre :Ifnar fl/fl mice suggests that the pathogenesis is likely driven by initial changes in neuroectodermal neurons rather than systemic or local immune activation. In agreement, neurons are crucial for regulation of CNS inflammation .
Protein degradation defects are common in neurodegenerative pathologies (Davies et al., 1997; Hara et al., 2006; Komatsu et al., 2006) . We found that endogenous neuronal IFN-b signaling is central in regulating protein degradation by autophagy, including clearing aged mitochondria. Accumulated aged and defective mitochondria may release reactive oxygen species, enhancing neuroinflammation and neuronal death (Chaturvedi and Flint Beal, 2013) . Cognitive and motoric impairments in PD is associated with DA dysfunction (Narayanan et al., 2013) . Excess cytosolic DA is degraded by monoamine oxidase (MAO) in the mitochondrial outer membrane and MAO defects might cause oxidative stress (Segura-Aguilar et al., 2014). Senescent and damaged mitochondria and reduced MAO mRNA were found in Ifnb -/-mice and reduced DOPAC in Ifnb -/-mice supported dysregulation of MAO and mitochondrial genes potentially contributing to neurotoxicity and DA neuron death. Lack of endogenous IFN-b signaling was associated with spontaneous neurodegeneration, impaired motor coordination and cognition, and neuronal LB-like inclusions with aging as seen in most PD and DLB patients (Jellinger, 2008) . Gene profiling supported essential IFN-b regulation of neuronal homeostasis. Neurotrophin was a top hit in GSEA and increased Tox mRNA, important for corticogenesis (Artegiani et al., 2015) , supported IFN-b effects on prosurvival mechanisms.
We showed that Ifnb gene therapy reversed pathology in a familial PD model, by promoting autophagy and a-syn clearance, which preserved DA neurons and associated neurologic deficit. Our data strongly support an essential role for IFN-b signaling in preventing neurodegenerative pathology and suggest Ifnb -/-mice as a model for nonfamilial, sporadic neurodegenerative diseases, particularly PD and DLB, with potential for testing future therapies.
EXPERIMENTAL PROCEDURES
For detailed procedures, see Supplemental Experimental Procedures.
Mice and Cell Culture
Ifnb -/-mice (Erlandsson et al., 1998) were housed in standard facilities. Sex-and weight-matched mice were used in experiments performed in accordance with the ethical committees in Denmark and approved by our institutional review boards. CGNs were from 6-or 7-day-old cerebella and cortical neuron (CN) cultures from the cortex of 1-day-old mice.
Behavioral Measurements
Motor-coordination and -learning were evaluated with an accelerating RotaRod (TSE Systems GmbH) automatically recording time before fall. Neuromuscular strength was tested by forelimb hanging time on a bar. Heat and cold tail-pain sensitivity was measured by tail-flick latency time after exposure. Spatial learning and reference memory were assessed with Morris water maze (Vorhees and Williams, 2006) with slight modifications. Swimming patterns were recorded with Ethovision 3.1 (Noldus Information Technology), measuring the time to reach a hidden platform during learning trials and frequency of platform position crossings during probe tests. Deficits prevalence were calculated as behavioral test scores of Ifnb -/-mice that deviated from the norm: mean value (SD/2) of the Ifnb +/+ group (Table S1 ).
In the cylinder tests, asymmetry in forelimb use during vertical exploration was used as a validated measure of akinesia in hemiparkinsonian rodents.
Cloning
Mouse Ifnb pCR4IFNb was from transOMIC (accession no. BC119395). Ifnb was transferred to pCSII-GW via pCR8TOPOGW (Invitrogen) with conventional cloning techniques to generate pCSII-IFNb. PCSII (without insert) was generated by lambda recombination with an empty pCR8GW vector. Plasmid inserts were verified by sequencing.
Surgery with AAV6-hSCNA AAV-GFP or AAV-human a-syn/hSNCA-WPRE (Vector Biolabs) together with lentiviral vectors pCSII-IFNb and pCSII control (3 ml for each virus) were injected unilaterally into 30 adult female Sprague Dawley rats (Taconic; 225-250 g at surgery). Virus was infused at 0.2 ml/min as described (Decressac et al., 2013) . (E) CNs expressing mRFP-GFP-LC3B with or without NH 4 Cl for 2 hr. Arrowheads, colocalized GFP and mRFP (autophagosomes); arrows, mRFP-only vesicles (autolysosomes). Scale bars, 10 mm; 2 mm in inserts. (F) Graphs, mean number of autophagosomes and autolysosomes/cell and vesicle ratio ± SEM, n = 3. (G) WB of Rab7. Graph, IOD of WB. Data are mean ± SEM of n = 3. (H) IF showing LC3B and p62 colocalized in autophagosomes (arrowheads) and LC3B, LAMP1, and p62 colocalizing in autolysosomes (arrows). Scale bars, 10 mm; 2 mm in inserts. For (B), (F), and (G), *p < 0.05, *p < 0.01, ***p < 0.001 by unpaired Student's t test. See also Figure S5 . embedded or brains were dissected and snap-frozen before sectioning. In vitro neuronal cultures were fixed in 4% PFA before staining. Tissues and cells were stained as described (Liu et al., 2014) .
For neurogenesis and BrdU staining, mice were injected intraperitoneally (i.p.) once per day (75 mg/g body weight) for 5 consecutive days and sacrificed 2 hr after last injection. Brains were processed and immunostained for BrdU and doublecortin (DCX).
MMP was measured by adding tetramethylrhodamine ethyl ester (TMRE) and Hoechst (Life Technologies) to primary CNs.
IF images were taken with a Zeiss LSM510 confocal scanning microscope and IN Cell Analyzer 2200 automated microscope. IHC images were taken with a NanoZoomer 2.0-HT digital slide scanner or Olympus BX51 microscope. Images were quantified with ImageJ (Fiji version), IN Cell Investigator, CellProfiler, Zeiss Zen, and Adobe Photoshop.
In situ apoptosis detection was with TUNEL kits (Calbiochem) with Hoechst counterstaining or DAB substrate and methyl green counterstaining kits (R&D Systems).
For transmission electron microscopy (TEM), 12-month-old mice were cardiac perfused with 2% PFA and 0.2% glutaraldehyde and paratenial, and central medial thalamic nuclei were dissected and processed for epon embedding and ultrathin sectioning. Samples were incubated with primary a-syn antibodies (Leica) and biotinylated (Vector Laboratories) or 1.4-nm gold-labeled secondary antibodies (Nanoprobes) and embedded in epoxy resin. Ultra-thin sections were analyzed in a Philips CM100 electron microscope. 
Stereological Analysis
The optical fractionator method was used to estimate neuron and glial numbers in the hippocampus of 80-mm mouse brain sections stained with H&E. Pointcounting techniques, based on the Cavalieri principle, were used to estimate hippocampal volume on one side of the brain.
Real-Time PCR Total RNA was isolated using a QIAGEN kit (QIAGEN), reverse transcribed into cDNA, amplified, and quantified by SYBR Green (Bio-Rad) detection. Relative mRNA expression was normalized with glyceraldehyde 3-phosphate dehydrogenase (Gapdh) gene.
High-Performance Liquid Chromatography
Striatum was dissected and homogenized. Filtered supernatant was examined for DA, DOPAC, and HVA levels by reversed-phase HPLCy (Decressac et al., 2013) .
Western Blots
Samples were lysed in 1% Triton X-100 (Sigma) and insoluble brain pellets were sonicated in UREA/SDS and processed as described (Ejlerskov et al., 2013) .
Affymetrix Microarrays
RNA was extracted with TRI (Sigma) and DNase I (Invitrogen) from 3-day-old Ifnb +/+ and Ifnb -/-CGN cultures in triplicate with or without 24 hr rIFN-b (100 U/ml). Affymetrix 430 2.0 microarray chip (SCIBLU, Affymetrix) data were analyzed with Arraystar 3 (DNA STAR) and quantile-normalized and processed by the RMA (Affymetrix) algorithm. We log 2 -transformed intensity values, and normal-distributed data were tested in unpaired two-tailed Student's t tests, filtering for differential regulation confidence of 95% (p < 0.05). Venn diagrams were created with oneChannelGUI (Bioconductor). Quantile-normalized RMA-treated data selected using a 1.4-fold cutoff were analyzed with Ingenuity Pathway Analysis software. GSEA data heatmaps were generated by extracting lists of core enriched genes from GSEA pathway analysis in R using Heatmap2 (Data S1).
Comparisons of Ifnb -/-CGN gene profiles and published PD and HD models using Affymetrix data (GSE4758, GSE9038) were quantile-normalized together and summarized in R using RMA algorithms from the Affy-package. Differential expression was determined individually within each experiment for our data and published PD and HD models by comparing control/WT samples with transgenic samples using standard ANOVA.
Statistical Analysis
Data were analyzed with unpaired and paired two-tailed Student's t tests, ANOVA, and Mann-Whitney U, and Kruskal-Wallis tests. p < 0.05 was significant. Error bars are SEM.
ACCESSION NUMBERS
The accession number for the raw microarray data reported in this paper is Gene Expression Omnibus: GSE63815. 
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